Salud financiera de hoja de balance de Marchex

Salud financiera controles de criterios 6/6

Marchex tiene un patrimonio de los accionistas total de $35.9M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $47.5M y $11.6M respectivamente.

Información clave

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	US$14.61m
Patrimonio	US$35.87m
Total pasivo	US$11.61m
Activos totales	US$47.48m

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($23.8M) de NHM superan a sus pasivos a corto plazo ($9.7M).

Pasivo a largo plazo: Los activos a corto plazo de NHM ($23.8M) superan a sus pasivos a largo plazo ($1.9M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: NHM está libre de deudas.

Reducción de la deuda: NHM no tenía deudas hace 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: NHM tiene suficiente cash runway para más de un año basándose en su flujo de caja libre actual.

Pronóstico de cash runway: NHM dispone de suficiente cash runway para 1.8 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 42.4% cada año.

Salud financiera de hoja de balance de Marchex

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

Marchex, Inc. to Report Q1, 2024 Results on May 07, 2024

Marchex Launches Generative Ai-Powered Sentiment Suite Across Multiple Apis

Marchex, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year of 2024

Full year 2023 earnings released: US$0.23 loss per share (vs US$0.19 loss in FY 2022)

Marchex, Inc. to Report Q4, 2023 Results on Mar 14, 2024

Third quarter 2023 earnings released: US$0.037 loss per share (vs US$0.036 loss in 3Q 2022)

Marchex, Inc. Provides Earnings Guidance for Fourth Quarter Ending December 31, 2023 and Fiscal Year 2024

New major risk - Revenue and earnings growth

Marchex, Inc. Launches Call Summary and Sentiment Suite Capabilities for Vertical Markets

Marchex, Inc. to Report Q3, 2023 Results on Nov 08, 2023

New major risk - Share price stability

Marchex, Inc., Annual General Meeting, Sep 28, 2023

New major risk - Financial position

Second quarter 2023 earnings released: US$64.56 loss per share (vs US$0.035 loss in 2Q 2022)

New minor risk - Share price stability

First quarter 2023 earnings released: US$0.10 loss per share (vs US$0.037 loss in 1Q 2022)

Full year 2022 earnings released: US$0.19 loss per share (vs US$0.10 loss in FY 2021)

Full year 2022 earnings released: US$0.20 loss per share (vs US$0.10 loss in FY 2021)

Marchex, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Marchex, Inc. Announces Executive Changes

Insufficient new directors

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Third quarter 2022 earnings released: US$0.038 loss per share (vs US$0.075 profit in 3Q 2021)

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Marchex, Inc. to Report Q3, 2022 Results on Nov 03, 2022

Marchex, Inc., Annual General Meeting, Sep 29, 2022

Second quarter 2022 earnings released: US$0.037 loss per share (vs US$0.008 loss in 2Q 2021)

Marchex, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Insufficient new directors

First quarter 2022 earnings released: US$0.037 loss per share (vs US$0.12 loss in 1Q 2021)

Marchex, Inc. Provides Earnings Guidance for the Second Quarter of 2022

Marchex, Inc. to Report Q1, 2022 Results on May 12, 2022

Insufficient new directors

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Marchex Inc. Launches Conversation Dna, Delivering Powerful Ai Signals Through Every Marchex Conversation Intelligence Product

Marchex, Inc. to Report Q4, 2021 Results on Mar 02, 2022

Third quarter 2021 earnings released: EPS US$0.083 (vs US$0.078 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.008 loss per share (vs US$0.096 loss in 2Q 2020)

First quarter 2021 earnings released: US$1.14 loss per share (vs US$0.53 loss in 1Q 2020)

Marchex, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2021

Marchex® Launches AI-powered SalesEngagement Solution

Full year 2020 earnings released: US$0.91 loss per share (vs US$0.21 loss in FY 2019)

Revenue misses expectations

Full year 2020 earnings released: US$0.98 loss per share (vs US$0.089 loss in FY 2019)

New 90-day high: €2.96

Marchex, Inc. to Report Q4, 2020 Results on Mar 02, 2021

New 90-day high: €2.44

Marchex Launches Marketing Edge, AI-Fueled Conversational Analytics Solution that Enables Brand Marketers and Agencies to More Effectively Drive Sales Conversations

Marchex, Inc. Announces Not to Provide Revenue Guidance for the Fourth Quarter of Fiscal Year 2020

Marchex, Inc. to Report Q3, 2020 Results on Nov 04, 2020

New 90-day high: €1.56

Marchex, Inc.(NasdaqGS:MCHX) dropped from S&P Global BMI Index

First half earnings released

Archenia, Inc. entered into definitive agreement to acquire Media Assets of Marchex, Inc. (NasdaqGS:MCHX).

Marchex, Inc. to Report Q2, 2020 Results on Aug 10, 2020

Marchex, Inc.(NasdaqGS:MCHX) dropped from Russell 2000 Dynamic Index

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera